Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis
Authors:
- Jj WaldJWJj Wald
- DA ForshewDFDA Forshew
- EL FeldmanEFEL Feldman
- Jw AlbersJAJw Albers
- 1 September 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 150 (1) , 59-62
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Factors influencing outcome of prednisone dose reduction in myasthenia gravisNeurology, 1991
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988
- Azathioprine toxicity during long‐term immunosuppression of generalized myasthenia gravisNeurology, 1988
- Preliminary Results of a Double-Blind, Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia GravisNew England Journal of Medicine, 1987
- Azathioprine toxicity in neuromuscular diseaseNeurology, 1986
- Neoplasia in Immunosuppressed Renal Transplant Patients: A 20-Year ExperienceSouthern Medical Journal, 1985
- Azathioprine in the treatment of myasthenia gravisAnnals of Neurology, 1984
- Long‐term corticosteriod treatment of myasthenia gravis: Report of 116 PatientsAnnals of Neurology, 1984
- CORTICOTROPIN AND CORTICOSTEROIDS IN GENERALIZED MYASTHENIA GRAVIS: COMPARATIVE STUDIES AND ROLE IN MANAGEMENTAnnals of the New York Academy of Sciences, 1976